Parmar, G.; Seftel, M.D.; Ganz, K.; Blake, J.; Holovati, J.L.; Allan, D.S.
Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation. Curr. Oncol. 2024, 31, 2542-2551.
https://doi.org/10.3390/curroncol31050190
AMA Style
Parmar G, Seftel MD, Ganz K, Blake J, Holovati JL, Allan DS.
Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation. Current Oncology. 2024; 31(5):2542-2551.
https://doi.org/10.3390/curroncol31050190
Chicago/Turabian Style
Parmar, Gaganvir, Matthew D. Seftel, Kathy Ganz, John Blake, Jelena L. Holovati, and David S. Allan.
2024. "Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation" Current Oncology 31, no. 5: 2542-2551.
https://doi.org/10.3390/curroncol31050190
APA Style
Parmar, G., Seftel, M. D., Ganz, K., Blake, J., Holovati, J. L., & Allan, D. S.
(2024). Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation. Current Oncology, 31(5), 2542-2551.
https://doi.org/10.3390/curroncol31050190